Sentences with phrase «program applications in»

This program includes complimentary ship and shore engineering assistance with incentive / rebate program applications in order to encourage plastic manufacturers to produce their products responsibly, efficiently, and effectively... Read More

Not exact matches

Linda Blaser, a contract recruiter for Exchange Applications, an IT company in Boston, has set up a referral program that gives employees more money for more valuable referrals: $ 3,000 for most positions and $ 5,000 for «hot jobs» that Blaser needs to fill with particular urgency.
In the application, Berkshire said that it did not buy new shares, but hit the threshold due to the buyback program of Wells.
Cases in point: Multiple versions with negligible feature differences are offered, you have to manually backup and reinstall data to upgrade from Windows XP, and certain programs (including e-mail and calendar applications) must be downloaded separately from the OS.
ENJOINED AND RESTRAINED from, in any manner or by any means, removing individuals with refugee applications approved by U.S. Citizenship and Immigration Services as part of the U.S. Refugee Admissions Program, holders of valid immigrant and non-immigrant visas, and other individuals from Iraq, Syria, Iran, Sudan, Libya, Somalia, and Yemen legally authorized to enter the United States.
The Tesla's «in - vehicle infotainment system» lacks an application programming interface — a way for programmers to tap into a computer system and write apps for it.
TechStars is loosely affiliated with 30 of these programs -; serving in an advisory capacity and allowing the programs to use its application -; and it runs TechStars programs in New York City, Boston, Seattle, San Antonio, and Boulder.
For those loan programs that do close down, the SBA will establish an online queue where small - business loan applications will be stacked in order that they are received.
Lotus 1 -2-3's cousin, Lotus Notes — which offered companies integrated messaging, business applications and social collaboration in one workspace — was the program that caught IBM's eye; Lotus 1 -2-3 simply tagged along because it was family.
Carly Gloge, a Canadian website and application design professional and the co-founder of Ubooly, got her sea legs with the toy at the famous TechStars accelerator program in Boulder in the summer of 2012.
The Social Security Administration received nearly 2.7 million applications for the program in 2013, up from 1.9 million a decade earlier, according to its most recent annual report.
Applications have climbed from 11 in 2010 — the program's first year — to 36 this summer.
In 1999, IDBs, previously considered an option for only large companies seeking multimillion - dollar loans, got a sleek new look with the creation of the mini-bond program, which offers a streamlined application process, capped fees and quick closings.
When HP tapped L?o Apotheker, the former CEO of SAP, Oracle's archrival in business - application programs, as its new commander - in - chief, Ellison charged HP with «[picking] a guy who was recently fired because he did such a bad job of running SAP,» and called for the board's immediate, «en masse» resignation.
Such drives usually come with a built - in pop - up program launcher called LaunchPad and a few programs, or they at least link to a Web page for downloading and installing free and for - pay U3 applications.
Earlier this month, it was revealed the number of applications for H - 1B visas — a similar, coveted program for companies to onboard specialized foreign labor — declined for the second year in a row, as the administration moves to streamline the program.
Individual or individuals making the application have a record of successful performance of contract work in the past, provided that those contracts (which may be from either government or private clients) are in the primary industry category in which the applicant is seeking program certification.
Google just announced it is buying Apigee, a specialist in application programming interfaces (APIs), for approximately $ 625 million in cash.
That's why in 2012 they launched New York City - based Temboo, a repository of programming processes that developers can use to connect to code utilities, databases and more than 100 application programming interfaces (APIs) for online services ranging from Amazon Web Services cloud storage to real - estate site Zillow.
Not all admissions officers say this will help an application get approved, but it shows your interest and engagement in the school's MBA program, which is exactly what they want to see.
Malware can be hidden, not just in applications or installation programs, but in what appear to be image and video files also.
Early in his career, Taylor helped create Google Maps and its application programming interface.
A time when applications to most two - year MBA programs are down, there's renewed and growing interest in accelerated programs.
Earlier in her career, she worked at the Centre for Addiction and Mental Health in Toronto, where she helped develop Ontario's Reduce Impaired Driving Everywhere (RIDE) program, but she was drawn to the application of psychology in management.
For example, many content - management systems have add - ons or plug - ins for mobile or social applications, such as a program that allows visitors to use their saved profile to register with your website rather than creating a new one.
Alternately, Antonopoulos suggests thinking of the «Bitcoin blockchain as having an API» (application programming interface) that makes its data usable by third parties, in the same way that second - layer services like Buffer or Hootsuite use the Twitter API to present and interact with Twitter data in slightly modified or reorganized forms.
The tech titan's BizSpark program, which offered thousands of dollars in free cloud credits, along with free access to Office 365 and Microsoft's Visual Studio developer tools, is no longer accepting new applications, and the company will be eliminating it once the benefits expire for companies already in the program.
Clio first opened up the platform in 2012 and in the past year «really doubled down» on its positioning, introducing a new application programming interface (API) that presented additional opportunities for developers.
The application's instructions are clear: In order to be accepted into TechStars, the prestigious accelerator program, start - up founders are asked to submit two videos — one to describe the company's product or service, and the other to introduce the team.
Applications to MBA programs went up 58 % in 2015, according to Canada's Graduate Management Admission Council.
«The Commission will not take adverse action on a license renewal application based upon the subjective determination of a listener or group of listeners that the station has broadcast purportedly inappropriate programming,» the FCC commissioners wrote in a recent decision challenging a local radio station license.
As Microsoft's Windows demonstrated in the PC era, technology markets in which third - party companies build programs or applications to run on top of a particular operating system or other product --» platform markets» — tend to standardize around one or two market leaders.
In the wake of last year's results, the Liberals moved up the opening of the application period, then extended it by two weeks in January when it looked like there would be a shortfall in businesses applying for the prograIn the wake of last year's results, the Liberals moved up the opening of the application period, then extended it by two weeks in January when it looked like there would be a shortfall in businesses applying for the prograin January when it looked like there would be a shortfall in businesses applying for the prograin businesses applying for the program.
The last element of the industry — the popular application program — didn't begin to fall into place until a meeting occurred between Dan Bricklin and Dan Fylstra in Boston in 1978.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Many applications development manager roles require candidates to have strong programming and analytical skills, as well as a bachelor's degree in computer science or engineering.
The program, which they named VisiCalc and introduced in October 1979, turned into the best - selling application program in history, with about 200,000 copies sold to date.
You may also authorize us to share your information with others, for example, with a third - party application when you give it access to your account, or with your employer when you choose to participate in an employee wellness program.
These programs allow self - employed individuals with significant experience in certain trades and professions to make an application for Canadian immigration.
There are a number of reasons for Amazon's newfound energy in advertising: It is doing more outreach with Madison Avenue, striking deals with holding companies and agencies; it opened an ad platform last year, an application programming interface that lets marketing developers build easier ways to buy ads; and it is opening its Amazon Ad Platform to more brands.
To this end, it offers short - term Junior Research Fellowships on an ongoing basis to Canadians who are currently enrolled in undergraduate or master's - level programs, or who have completed their degree programs within 12 months of the application deadline.
The MaRS clients chosen to participate in the program produce a range of technology applications:
What separates decentralized applications from standard applications is the infrastructure of their back - end servers, omitting the use of programming languages such as Rails or Django in favor of blockchain technology — removing centralized hosting services and putting power and voice back in the hands of its users.
The Vancouver Board of Trade is also pleased to see the investment in application processing by the NEB, and a continued commitment to workforce training and strengthening Canada's labour market, including the creation of the Canada Apprentice Loan program and assistance for persons with disabilities.
July marks the beginning of our annual Entrepreneur Season, when we unveil a full calendar of unique events for the community and open applications for participation in our entrepreneur support programs.
Cambridge, MA — February 6, 2017 — Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug application (IND) for the company's lead program, light - activated AU - 011 in ocular melanoma (OM).
They're not necessarily going to be the ones to sit down and code the algorithms, but they have been exposed right in the program to what these technologies can do, and see the business applications.
Applications will be due February 23, 2018, and this year's program will be held June 17 - 22, 2018 at the WBENC National Conference & Business Fair in Detroit, MI.
After the application process for the 4th generation, which took place in July, 29 young startups have been chosen to be part of the flagship entrepreneurial program of the Chilean government.
In special instances, Joey offers an application - only, group coaching program for up to ten CEOs / entrepreneurs operating within the same industry.
a b c d e f g h i j k l m n o p q r s t u v w x y z